1. Home
  2. YDES vs IMKTA Comparison

YDES vs IMKTA Comparison

Compare YDES & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YDES
  • IMKTA
  • Stock Information
  • Founded
  • YDES 2013
  • IMKTA 1963
  • Country
  • YDES Taiwan
  • IMKTA United States
  • Employees
  • YDES N/A
  • IMKTA N/A
  • Industry
  • YDES
  • IMKTA Food Chains
  • Sector
  • YDES
  • IMKTA Consumer Staples
  • Exchange
  • YDES Nasdaq
  • IMKTA Nasdaq
  • Market Cap
  • YDES 1.1B
  • IMKTA 1.3B
  • IPO Year
  • YDES N/A
  • IMKTA N/A
  • Fundamental
  • Price
  • YDES $18.00
  • IMKTA $71.17
  • Analyst Decision
  • YDES
  • IMKTA
  • Analyst Count
  • YDES 0
  • IMKTA 0
  • Target Price
  • YDES N/A
  • IMKTA N/A
  • AVG Volume (30 Days)
  • YDES 103.6K
  • IMKTA 108.9K
  • Earning Date
  • YDES 09-30-2025
  • IMKTA 08-07-2025
  • Dividend Yield
  • YDES N/A
  • IMKTA 0.94%
  • EPS Growth
  • YDES N/A
  • IMKTA N/A
  • EPS
  • YDES N/A
  • IMKTA 2.97
  • Revenue
  • YDES $510,360.00
  • IMKTA $5,363,138,171.00
  • Revenue This Year
  • YDES N/A
  • IMKTA N/A
  • Revenue Next Year
  • YDES N/A
  • IMKTA N/A
  • P/E Ratio
  • YDES N/A
  • IMKTA $24.01
  • Revenue Growth
  • YDES 45.76
  • IMKTA N/A
  • 52 Week Low
  • YDES $5.30
  • IMKTA $58.92
  • 52 Week High
  • YDES $25.00
  • IMKTA $75.63
  • Technical
  • Relative Strength Index (RSI)
  • YDES N/A
  • IMKTA 58.79
  • Support Level
  • YDES N/A
  • IMKTA $68.30
  • Resistance Level
  • YDES N/A
  • IMKTA $72.87
  • Average True Range (ATR)
  • YDES 0.00
  • IMKTA 1.69
  • MACD
  • YDES 0.00
  • IMKTA 0.06
  • Stochastic Oscillator
  • YDES 0.00
  • IMKTA 68.42

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: